World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
76
Citations
20638
World Ranking
1417
National Ranking
617

Overview

John N. Galgiani is affiliated with the University of Arizona in the United States and has authored a significant number of publications, primarily in the field of Medicine. Their research emphasizes areas such as Epidemiology, Infectious Diseases, and specifically fungal infections and related studies.

The scientist's main topics of work include:

  • Fungal Infections and Studies
  • Antifungal Resistance and Susceptibility
  • Infectious Diseases and Mycology
  • Phytoplasmas and Hemiptera Pathogens
  • Nail Diseases and Treatments
  • Immunodeficiency and Autoimmune Disorders
  • Toxoplasma gondii Research Studies

Frequent collaborators include:

  • Fariba Donovan
  • Lisa F. Shubitz
  • Daniel A. Powell
  • Jeffrey A. Frelinger
  • Steven M. Holland

The most common publication venues are:

  • Clinical Infectious Diseases
  • Journal of Fungi
  • Open Forum Infectious Diseases
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Frontiers in Cellular and Infection Microbiology

Recent publications illustrate the scope of John N. Galgiani's work:

  • "Comparison of a Novel Rapid Lateral Flow Assay to Enzyme Immunoassay Results for Early Diagnosis of Coccidioidomycosis", 2020, Clinical Infectious Diseases
  • "Immunogenetics associated with severe coccidioidomycosis", 2022, JCI Insight
  • "Coccidioidomycosis and Histoplasmosis in Immunocompetent Persons", 2024, New England Journal of Medicine
  • "Natural History of Disseminated Coccidioidomycosis: Examination of the Veterans Affairs-Armed Forces Database", 2020, Clinical Infectious Diseases
  • "Differential Thermotolerance Adaptation between Species of Coccidioides", 2020, Journal of Fungi

Best Publications

  • Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections

    John H. Rex;Michael A. Pfaller;John N. Galgiani;Marilyn S. Bartlett

  • The role of understaffing in central venous catheter-associated bloodstream infections

    Scott K. Fridkin;Suzanne M. Pear;Theresa H. Williamson;John N. Galgiani

  • NIAID mycoses study group multicenter trial of oral itraconazole therapy for invasive aspergillosis

    David W. Denning;David W. Denning;Jeanette Y. Lee;Jeanette Y. Lee;John S. Hostetler;John S. Hostetler;Peter Pappas;Peter Pappas

  • 2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis

    John N. Galgiani;Neil M. Ampel;Janis E. Blair;Antonino Catanzaro

  • An insight into the antifungal pipeline: selected new molecules and beyond.

    Luis Ostrosky-Zeichner;Arturo Casadevall;John N. Galgiani;Frank C. Odds

  • Comparative genomic analyses of the human fungal pathogens Coccidioides and their relatives

    Thomas J. Sharpton;Jason E. Stajich;Steven D. Rounsley;Malcolm J. Gardner

  • Practice Guidelines for the Treatment of Coccidioidomycosis

    John N. Galgiani;John N. Galgiani;John N. Galgiani;Neil M. Ampel;Neil M. Ampel;Neil M. Ampel;Antonino Catanzaro;Royce H. Johnson

  • Antifungal susceptibility testing.

    J H Rex;M A Pfaller;M G Rinaldi;A Polak

  • Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests.

    A Espinel-Ingroff;C W Kish;T M Kerkering;R A Fromtling

  • Coccidioidomycosis as a common cause of community-acquired pneumonia.

    Lisa Valdivia;David Nix;Mark Wright;Elizabeth Lindberg

  • Comparison of Oral Fluconazole and Itraconazole for Progressive, Nonmeningeal Coccidioidomycosis: A Randomized, Double-Blind Trial

    J N Galgiani;A Catanzaro;G A Cloud;R H Johnson

  • Decrease in Nosocomial Clostridium difficile–Associated Diarrhea by Restricting Clindamycin Use

    Suzanne M. Pear;Theresa H. Williamson;Kristine M. Bettin;Dale N. Gerding

  • Recent Advances in Our Understanding of the Environmental, Epidemiological, Immunological, and Clinical Dimensions of Coccidioidomycosis

    Chinh Nguyen;Bridget Marie Barker;Susan Hoover;David E. Nix

  • Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts.

    R A Fromtling;J N Galgiani;M A Pfaller;A Espinel-Ingroff

  • Collaborative investigation of variables in susceptibility testing of yeasts.

    M A Pfaller;M G Rinaldi;J N Galgiani;M S Bartlett

  • Detection of amphotericin B-resistant Candida isolates in a broth-based system.

    J. H. Rex;C. R. Cooper;W. G. Merz;J. N. Galgiani

  • Disposition of ketoconazole, an oral antifungal, in humans.

    C Brass;J N Galgiani;T F Blaschke;R Defelice

  • Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivo.

    T E Rogers;J N Galgiani

  • Coccidioidomycosis in the acquired immunodeficiency syndrome.

    Danetta A. Bronnimann;Rodney D. Adam;John N. Galgiani;Michael P. Habib

  • Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis

    Elizabeth P. Sampaio;Elizabeth P. Sampaio;Amy P. Hsu;Joseph Pechacek;Hannelore I. Bax;Hannelore I. Bax

  • Coccidioidomycosis during human immunodeficiency virus infection. A review of 77 patients.

    Douglas G. Fish;Neil M. Ampel;Neil M. Ampel;John N. Galgiani;Cynthia L. Dols

Frequent Co-Authors

David A. Stevens
David A. Stevens Stanford University
William E. Dismukes
William E. Dismukes University of Alabama at Birmingham
John R. Graybill
John R. Graybill The University of Texas Health Science Center at San Antonio
John H. Rex
John H. Rex The University of Texas Health Science Center at Houston
Paul Keim
Paul Keim Northern Arizona University
Jeffrey A. Frelinger
Jeffrey A. Frelinger University of Arizona
Michael G. Rinaldi
Michael G. Rinaldi The University of Texas Health Science Center at San Antonio
Michael A. Pfaller
Michael A. Pfaller JMI Laboratories
Carol A. Kauffman
Carol A. Kauffman University of Michigan–Ann Arbor
Steven M. Holland
Steven M. Holland National Institute of Allergy and Infectious Diseases

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to diverse career options, many of which can be pursued through specialized online degrees. For example, healthcare-related fields continue to grow, with roles like Functional Medicine Nurse Practitioners offering competitive salaries and unique approaches to patient care. If you're interested in such paths, exploring information on functional medicine nurse salary can provide valuable insights.

Beyond healthcare, certification programs like the Certified Professional Coder (CPC) offer career stability and are accessible through online education. Those curious about the requirements and opportunities should review details on cpc certification.

For individuals with unique backgrounds, including felons seeking educational opportunities, there are inclusive options available. Some online degrees cater to such students, helping them build new career pathways. More on this can be found in degrees for felons.

Finally, specialized roles like Child Life Specialists combine science and care for vulnerable populations. Understanding their compensation can help assess career viability; explore how much do child life specialists make for further information.

Best Scientists Citing John N. Galgiani

Trending Scientists

Recently Published Articles